Upacicalcet sodium is a pharmaceutical raw material used in the manufacturing of active pharmaceutical ingredients. It is a salt-form compound containing a sulfonate group and an amino acid moiety, designed for intravenous administration in dialysis patients with secondary hyperparathyroidism.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2052969-18-1
Amifostine
cytoprotective adjuvant for chemoradiotherapy
(-)-parthenolide
pharmaceutical raw material
Oxibendazole
pharmaceutical raw material
(2S)-N-[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]-2-amino-3-methylbutanamide
pharmaceutical raw material
sodium 3-[[(2S)-2-amino-2-carboxyethyl]carbamoylamino]-5-chloro-4-methylbenzenesulfonate
KUQQRUUFBPFDOW-QRPNPIFTSA-M
CC1=C(C=C(C=C1Cl)S(=O)(=O)[O-])NC(=O)NC[C@@H](C(=O)O)N.[Na+]